HomePage - Onconova Therapeutics, Inc.

About Us

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of targeted anti-cancer agents designed to work against specific cellular pathways that promote cancer.

News and Events

Onconova Announces Presentation of Oral Rigosertib Safety and Activity Data in Lower Risk Myelodysplastic Syndromes at the 2013 ASCO Annual Meeting
15 May 2013

Onconova Completes Enrollment in ONTIME Pivotal Phase 3 Study of Rigosertib in Patients with High-risk Myelodysplastic Syndromes
9 May 2013

Onconova Announces Presentation of Positive Data of Oral Rigosertib in Advanced Head and Neck Cancer at AACR 2013 Annual Meeting
9 April 2013

Onconova Appoints Ajay Bansal as Chief Financial Officer
2 April 2013